Synthesis, Characterization, and Biological Evaluation of Osmium(IV) Pyrazole Carbothioamide Complexes

References

• J. M. Gichumbi and H. B. Friedrich, “Half-Sandwich Complexes of Platinum Group Metals (Ir, Rh, Ru and Os) and Some Recent Biological and Catalytic Applications,” Journal of Organometallic Chemistry 866, (2018): 123–43.
   Web of Science ®Google Scholar
• M. Hanif, S. Moon, M. P. Sullivan, S. Movassaghi, M. Kubanik, D. C. Goldstone, T. Söhnel, S. M. F. Jamieson, and C. G. Hartinger, “Anticancer Activity of Ru- and Os(Arene) Compounds of a Maleimide-Functionalized Bioactive Pyridinecarbothioamide Ligand,” Journal of Inorganic Biochemistry 165, (2016): 100–7.
   PubMed Web of Science ®Google Scholar
• J. Dong, Q. Zhang, Z. Wang, G. Huang, and S. Li, “Recent Advances in the Development of Indazole-Based Anticancer Agents,” Chemmedchem 13, no. 15 (2018): 1490–507.
   PubMed Web of Science ®Google Scholar
• D. Aucamp, S. V. Kumar, D. C. Liles, M. A. Fernandes, L. Harmse, and D. I. Bezuidenhout, “Synthesis of Heterobimetallic Gold(i) Ferrocenyl-Substituted 1,2,3-Triazol-5-Ylidene Complexes as Potential Anticancer Agents,” Dalton Transactions (Cambridge, England : 2003) 47, no. 45 (2018): 16072–81.
   PubMed Web of Science ®Google Scholar
• A. Gatti, A. Habtemariam, I. Romero-Canelón, J.-I. Song, B. Heer, G. J. Clarkson, D. Rogolino, P. J. Sadler, and M. Carcelli, “Half-Sandwich Arene Ruthenium(II) and Osmium(II) Thiosemicarbazone Complexes: Solution Behavior and Antiproliferative Activity,” Organometallics 37, no. 6 (2018): 891–9.
   PubMed Web of Science ®Google Scholar
• C. C. Konkankit, S. C. Marker, K. M. Knopf, and J. J. Wilson, “Anticancer Activity of Complexes of the Third Row Transition Metals, Rhenium, Osmium, and Iridium,” Dalton Transactions (Cambridge, England: 2003) 47, no. 30 (2018): 9934–74.
   PubMed Web of Science ®Google Scholar
• S. Shahraki, M. Saeidifar, F. Shiri, and A. Heidari, “Synthesis, Characterization, Cytotoxicity and Detailed HSA Interaction of New Zinc(II) Complexes Containing Dithiocarbamate and Heterocyclic N-Donor Ligands,” Polycyclic Aromatic Compounds 39, no. 3 (2019): 220–37.
   Web of Science ®Google Scholar
• S. Alcaro, M. L. Bolognesi, A. T. García-Sosa, and S. Rapposelli, “Editorial: Multi-*Target-Directed Ligands (MTDL) as Challenging Research Tools in Drug Discovery: From Design to Pharmacological Evaluation,” Frontiers in Chemistry 7, (2019): 71.
   PubMed Web of Science ®Google Scholar
• A. Arsiwala, A. Castro, S. Frey, M. Stathos, and R. S. Kane, “Designing Multivalent Ligands to Control Biological Interactions: From Vaccines and Cellular Effectors to Targeted Drug Delivery,” Chemistry, an Asian Journal 14, no. 2 (2019): 244–55.
   PubMed Web of Science ®Google Scholar
• N. E. Md Yusof, B. T. Ravoof, R. E. Tiekink, A. Veerakumarasivam, A. K. Crouse, I. M. Mohamed Tahir, and H. Ahmad, “Synthesis, Characterization and Biological Evaluation of Transition Metal Complexes Derived from N, S Bidentate Ligands,” International Journal of Molecular Sciences 16, no. 12 (2015): 11034–54.
   PubMedGoogle Scholar
• B. Shafaatian, S. S. Mousavi, and S. Afshari, “Synthesis, Characterization, Spectroscopic and Theoretical Studies of New Zinc(II), Copper(II) and Nickel(II) Complexes Based on Imine Ligand Containing 2-Aminothiophenol Moiety,” Journal of Molecular Structure 1123, (2016) : 191–8.
   Web of Science ®Google Scholar
• T. V. Sravanthi, and S. L. Manju, “Indoles – A Promising Scaffold for Drug Development,” European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 91, (2016) : 1–10.
   PubMed Web of Science ®Google Scholar
• D. G. Goswami, N. Tewari-Singh, D. Dhar, D. Kumar, C. Agarwal, D. A. Ammar, R. Kant, R. W. Enzenauer, J. M. Petrash, and R. Agarwal, “Nitrogen Mustard-Induced Corneal Injury Involves DNA Damage and Pathways Related to Inflammation, Epithelial-Stromal Separation, and Neovascularization,” Cornea 35, no. 2 (2016): 257–66.
   PubMed Web of Science ®Google Scholar
• P. Patel, J. Pillai, N. Darji, and B. Patel, “Recent Advance in Anti Inflammatory Activity of Benzothiazole Derivatives,” International Journal of Drug Research and Technology 2, no. 2 (2012), 170–76.
   Google Scholar
• D. Havrylyuk, O. Roman, and R. Lesyk, “Synthetic Approaches, Structure Activity Relationship and Biological Applications for Pharmacologically Attractive Pyrazole/Pyrazoline-Thiazolidine-Based Hybrids,” European Journal of Medicinal Chemistry 113, (2016): 145–66.
   PubMed Web of Science ®Google Scholar
• O. Dömötör, M. A. Kiss, G. T. Gál, N. V. May, G. Spengler, M. Nové, A. Č. Gašparović, É. Frank, and É. A. Enyedy, “Solution Equilibrium, Structural and Cytotoxicity Studies on Ru(η6-p-Cymene) and Copper Complexes of Pyrazolyl Thiosemicarbazones,” Journal of Inorganic Biochemistry 202, (2020): 110883.
   PubMed Web of Science ®Google Scholar
• M. F. El Shehry, M. M. Ghorab, S. Y. Abbas, E. A. Fayed, S. A. Shedid, and Y. A. Ammar, “Quinoline Derivatives Bearing Pyrazole Moiety: Synthesis and Biological Evaluation as Possible Antibacterial and Antifungal Agents,” European Journal of Medicinal Chemistry 143, (2018): 1463–73.
   PubMed Web of Science ®Google Scholar
• L.-G. Yu, T.-F. Ni, W. Gao, Y. He, Y.-Y. Wang, H.-W. Cui, C.-G. Yang, and W.-W. Qiu, “The Synthesis and Antibacterial Activity of Pyrazole-Fused Tricyclic Diterpene Derivatives,” European Journal of Medicinal Chemistry 90, (2015): 10–20.
   PubMed Web of Science ®Google Scholar
• G. Kumar, O. Tanwar, J. Kumar, M. Akhter, S. Sharma, C. R. Pillai, M. M. Alam, and M. S. Zama, “Pyrazole-Pyrazoline as Promising Novel Antimalarial Agents: A Mechanistic Study,” European Journal of Medicinal Chemistry 149, (2018): 139–47.
   PubMed Web of Science ®Google Scholar
• S. M. Gomha, T. A. Salah, and A. O. Abdelhamid, “Synthesis, Characterization, and Pharmacological Evaluation of Some Novel Thiadiazoles and Thiazoles Incorporating Pyrazole Moiety as Anticancer Agents,” Monatshefte Für Chemie – Chemical Monthly 146, no. 1 (2015): 149–58.
   Google Scholar
• M. M. Aghazadeh Attari, C. Ostadian, A. A. Saei, A. Mihanfar, S. G. Darband, S. Sadighparvar, M. Kaviani, H. Samadi, B. Yousefi, and M. Majidinia, “DNA Damage Response and Repair in Ovarian Cancer: Potential Targets for Therapeutic Strategies,” DNA Repair 80, (2019): 59–84.
   PubMed Web of Science ®Google Scholar
• E. V. Minten and D. S. Yu, “DNA Repair: Translation to the Clinic,” Clinical Oncology (Royal College of Radiologists (Great Britain)) 31, no. 5 (2019): 303–10.
   PubMed Web of Science ®Google Scholar
• Z. Zhao, J. Zhang, S. Zhi, W. Song, and J. a. Zhao, “Novel Binuclear and Trinuclear Metal (II) Complexes: DNA Interactions and in Vitro Anticancer Activity through Apoptosis,” Journal of Inorganic Biochemistry 197, (2019): 110696.
   PubMed Web of Science ®Google Scholar
• M. Sankarganesh, J. Dhaveethu Raja, K. Sakthikumar, R. V. Solomon, J. Rajesh, S. Athimoolam, and V. Vijayakumar, “New Bio-sensitive and Biologically Active Single Crystal of Pyrimidine Scaffold Ligand and its Gold and Platinum Complexes: DFT, Antimicrobial, Antioxidant, DNA Interaction, Molecular Docking with DNA/BSA and Anticancer Studies,” Bioorganic Chemistry 81, (2018): 144–56.
   PubMed Web of Science ®Google Scholar
• B. J. Pages, D. L. Ang, E. P. Wright, and J. R. Aldrich-Wright, “Metal Complex Interactions with DNA,” Dalton Transactions 44, no. 8 (2015): 3505–26.
   PubMed Web of Science ®Google Scholar
• B. Annaraj, C. Balakrishnan, and M. A. Neelakantan, “Synthesis, Structure Information, DNA/BSA Binding Affinity and in Vitro Cytotoxic Studies of Mixed Ligand Copper(II) Complexes Containing a Phenylalanine Derivative and Diimine co-Ligands,” Journal of Photochemistry and Photobiology. B, Biology 160, (2016): 278–91.
   PubMed Web of Science ®Google Scholar
• U. Ndagi, N. Mhlongo, and M. E. Soliman, “Metal Complexes in Cancer Therapy – An Update from Drug Design Perspective,” Drug Design, Development and Therapy 11, (2017): 599–616.
   PubMed Web of Science ®Google Scholar
• R. Subashini, F. R. Nawaz Khan, M. Gund, V. R. Hathwar, and S. Weng Ng, “2-Chloro-6-Methoxyquinoline-3-Carbaldehyde,” 65, (2009): 2723.
   Google Scholar
• F. Boudjellal, H. B. Ouici, A. Guendouzi, O. Benali, and A. Sehmi, “Experimental and Theoretical Approach to the Corrosion Inhibition of Mild Steel in Acid Medium by a Newly Synthesized Pyrazole Carbothioamide Heterocycle,” Journal of Molecular Structure 1199, (2020): 127051.
   Web of Science ®Google Scholar
• A. Sehmi, H. B. Ouici, A. Guendouzi, M. Ferhat, O. Benali, and F. Boudjellal, “Corrosion Inhibition of Mild Steel by Newly Synthesized Pyrazole Carboxamide Derivatives in HCl Acid Medium: Experimental and Theoretical Studies,” Journal of the Electrochemical Society 167, no. 15 (2020): 155508.
   Web of Science ®Google Scholar
• P. A. Lay, and A. M. Sargeson, “Tris(1,2-Ethanediamine) Complexes of Osmium(IV), Osmium(III) and Osmium(II): Oxidative Dehydrogenation Reactions,” Inorganica Chimica Acta 198–200, (1992): 449–60.
   Web of Science ®Google Scholar
• K. Maruyama, Y. Mishima, K. Minagawa, and J. Motonaka, “Electrochemical and DNA-Binding Properties of Dipyridophenazine Complexes of Osmium(II),” 510, (2001): 96–102.
   Google Scholar
• B. Kavitha, M. Sravanthi, and P. Saritha Reddy, “DNA Interaction, Docking, Molecular Modelling and Biological Studies of o-Vanillin Derived Schiff Base Metal Complexes,” Journal of Molecular Structure 1185, (2019): 153–67.
   Web of Science ®Google Scholar
• M. Dehkhodaei, M. Sahihi, H. Rudbari, and F. Momenbeik, “DNA and HSA Interaction of Vanadium (IV), Copper (II), and Zinc (II) Complexes Derived from an Asymmetric Bidentate Schiff-Base Ligand: Multi Spectroscopic, Viscosity Measurements, Molecular Docking, and ONIOM Studies,” Journal of Biological Inorganic Chemistry 23, (2017), 181–92.
   Google Scholar
• Z. Mirzaei-Kalar, “In Vitro Binding Interaction of Atorvastatin with Calf Thymus DNA: Multispectroscopic, Gel Electrophoresis and Molecular Docking Studies,” Journal of Pharmaceutical and Biomedical Analysis 161, (2018): 101–9.
   PubMed Web of Science ®Google Scholar
• S. Banerjee, M. Selim, A. Saha, and K. K. Mukherjea, “Radiation Induced DNA Damage and Its Protection by a Gadolinium(III) Complex: Spectroscopic, Molecular Docking and Gel Electrophoretic Studies,” International Journal of Biological Macromolecules 127, (2019): 520–8.
   PubMed Web of Science ®Google Scholar
• S. Bi, H. Zhou, J. Wu, and X. Sun, “Micronomicin/Tobramycin Binding with DNA: Fluorescence Studies Using of Ethidium Bromide as a Probe and Molecular Docking Analysis,” Journal of Biomolecular Structure & Dynamics 37, no. 6 (2019): 1464–76.
   PubMed Web of Science ®Google Scholar
• N. M. Mallikarjuna, J. Keshavayya, and B. N. Ravi, “Synthesis, Spectroscopic Characterization, Antimicrobial, Antitubercular and DNA Cleavage Studies of 2-(1H-Indol-3-Yldiazenyl)-4, 5, 6, 7-Tetrahydro-1, 3-Benzothiazole and Its Metal Complexes,” Journal of Molecular Structure 1173, (2018): 557–66.
   Web of Science ®Google Scholar
• T. Ur Rehman, A-U Khan, A. Abbas, J. Hussain, F. U. Khan, K. Stieglitz, and S. Ali, “Investigation of Nepetolide as a Novel Lead Compound: Antioxidant, Antimicrobial, Cytotoxic, Anticancer, anti-Inflammatory, Analgesic Activities and Molecular Docking Evaluation,” Saudi Pharmaceutical Journal 26, no. 3 (2018): 422–9.
   PubMed Web of Science ®Google Scholar
• K. P. Thakor, M. V. Lunagariya, B. S. Bhatt, and M. N. Patel, “Fluorescence and Absorption Studies of DNA-Pd(II) Complex Interaction: Synthesis, Spectroanalytical Investigations and Biological Activities ,” Luminescence: The Journal of Biological and Chemical Luminescence 34, no. 1 (2019): 113–24.
   PubMed Web of Science ®Google Scholar
• S. Swavey, K. Morford, M. Tsao, K. Comfort, and M. K. Kilroy, “Heteroleptic Monometallic and Trimetallic Ruthenium(II) Complexes Incorporating a π-Extended Dipyrrin Ligand: Light-Activated Reactions with the A549 Lung Cancer Cell Line,” Journal of Inorganic Biochemistry 175, (2017): 101–9.
   PubMed Web of Science ®Google Scholar
• P. Zhang, and H. Huang, “Future Potential of Osmium Complexes as Anticancer Drug Candidates, Photosensitizers and Organelle-Targeted Probes,” Dalton Transactions (Cambridge, England: 2003) 47, no. 42 (2018): 14841–54.
   PubMed Web of Science ®Google Scholar
• K. Maruyama, Y. Mishima, K. Minagawa, and J. Motonaka, “Electrochemical and DNA-Binding Properties of Dipyridophenazine Complexes of Osmium(II),” Journal of Electroanalytical Chemistry 510, no. 1–2 (2001): 96–102.
   Web of Science ®Google Scholar
• B. H. Pursuwani, B. S. Bhatt, F. U. Vaidya, C. Pathak, and M. N. Patel, “Tetrazolo[1,5-a]Quinoline Moiety-Based Os(IV) Complexes: DNA Binding/Cleavage, Bacteriostatic and Photocytotoxicity Assay,” Journal of Biomolecular Structure and Dynamics (2020): 1–10.doi: 10.1080/07391102.2020.1756912
   PubMed Web of Science ®Google Scholar
• W. Ginzinger, G. Mühlgassner, V. Arion, M. Jakupec, A. Roller, M. Galanski, M. Reithofer, W. Berger, and B. Keppler, “A SAR Study of Novel Antiproliferative Ruthenium and Osmium Complexes with Quinoxalinone Ligands in Human Cancer Cell Lines,” Journal of Medicinal Chemistry 55, no. 7 (2012): 3398–413.
   PubMed Web of Science ®Google Scholar
• S. B. Gajera, J. V. Mehta, D. N. Kanthecha, R. R. Patel, and M. N. Patel, “Novel Cytotoxic Oxovanadium(IV) Complexes: Influence of Pyrazole-Incorporated Heterocyclic Scaffolds on Their Biological Response,” Applied Organometallic Chemistry 31, no. 11 (2017): e3767.
   Web of Science ®Google Scholar